Our News on Newswise

Immunotherapy Drug Development Pipeline Continues Significant Growth in 2020 Despite Global Pandemic Impact

Despite the impact of the COVID-19 pandemic across the globe, there has been a resurgence of interest in immuno-oncology (I-O) preclinical and clinical development, bringing hope to cancer patients and physicians who treat them.
18-Sep-2020 8:30 AM EDT Add to Favorites

Newswise: virtual_patient_summit_logo_2000px.png

Cancer Research Institute Goes Virtual for Its Immunotherapy Patient Summit Series, Connecting Patients and Caregivers with Leading Experts in Cancer Immunotherapy

Free virtual event October 2-3 connecting cancer patients and caregivers with leading immunotherapy experts and patient advocates treated with immunotherapy
17-Sep-2020 4:45 PM EDT Add to Favorites

Cancer Research Institute Announces Recipients of 2020 Philanthropy and Science Awards to Be Presented at Virtual Gala, Innovators in Science and Philanthropy

Honorees recognized for supporting and making significant scientific advancements in cancer immunotherapy research to help create better treatment options for cancer patients
10-Sep-2020 7:00 AM EDT Add to Favorites

Cancer Research Institute Awards $30.2 Million in Grants and Fellowships to Support Basic and Clinical Research in Immunology and Cancer Immunotherapy

The Cancer Research Institute (CRI), a U.S. nonprofit organization dedicated to the discovery and development of powerful immunotherapies for all cancers, awarded more than $30.2 million in research grants and fellowships in the 2020 fiscal year...
5-Aug-2020 2:00 PM EDT Add to Favorites

Cancer Research Institute and The Mark Foundation for Cancer Research Launch Collaboration to Evaluate Liquid Biopsy for More Accurate and Rapid Assessment of Lung Cancer Patient Response to Immunotherapy

The Cancer Research Institute (CRI) and The Mark Foundation for Cancer Research have launched a clinical trial that aims to demonstrate the utility of a novel, ultra-sensitive biomarker-directed blood test, or liquid biopsy, in assessing cancer...
29-Jul-2020 8:55 AM EDT Add to Favorites

Newswise: cim_logo.png

Eighth Annual Cancer Immunotherapy Month™ in June Celebrates Progress in Treatment and Advances in Research

June is Cancer Immunotherapy Month, a 30-day awareness campaign started by the Cancer Research Institute eight years ago to educate, inform, and inspire the global community of patients, caregivers, scientists, donors, and other cancer-concerned...
1-Jun-2020 11:40 AM EDT Add to Favorites

Rapid Growth in Global Development of Cancer Cellular Immunotherapies Highlighted by Latest Report from Cancer Research Institute and GlobalData

A new report, published in Nature Reviews Drug Discovery, reveals that the cellular immunotherapy landscape continues to expand, with 472 more cellular therapies in development now than one year ago
26-May-2020 9:00 AM EDT Add to Favorites

Newswise: iqvialogo.png

Cancer Research Institute and IQVIA Uncover the Impact of COVID-19 Pandemic on Global Oncology Clinical Trials

New study reveals impact of COVID-19 pandemic on cancer clinical trials, published in Nature Reviews Drug Discovery
18-May-2020 10:05 AM EDT Add to Favorites


See All News

Our Experts on Newswise

Expert Available for Commentary on Recent FDA Analysis of TNF Blockers

The FDA announced on Aug 4 2009 that tumor necrosis factor (TNF) blockers used in the treatment of immune disorders carry an increased risk of lymphoma and other cancers in children and adolescents. The discoverer of TNF-alpha, Lloyd J. Old, M.D., a...
7-Aug-2009 9:00 AM EDT

PROVENGE Cancer Vaccine Heralds New Dawn in Cancer Therapy

Dendreon's PROVENGE for the treatment of advanced prostate cancer is the first active cellular immunotherapy to prolong patient survival, according to data from a pivotal phase III clinical trial announced at yesterday's AUA annual meeting in...
29-Apr-2009 11:20 AM EDT

See All Experts

Our YouTube Videos

About

The mission of the Cancer Research Institute is to save more lives by fueling the discovery and development of powerful immunotherapies for all types of cancer.

Contacts

Brian Brewer
Director of Marketing and Communications

bbrewer@cancerresearch.org

212-688-7515

Elliot Fox

efox@w20group.com

Twitter

close
0.32266